Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Rowen

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Epilepsy & Behavior : E&B|May 20, 2014
Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general populationBrendan Mulhern, Donna Rowen, Dee Snape, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Deriving a preference-based measure for cancer using the EORTC QLQ-C30Donna Rowen, John Brazier, Tracey Young, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 17, 2015
Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of LifeDonna Rowen, John Brazier, Clara Mukuria, et al.
Pharmacoeconomics|June 11, 2026
Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with DurationEun-Young Bae, Jahyun Cho, Jooho Moon, et al.
Journal of Patient-Reported Outcomes|February 28, 2024
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosisClara Mukuria, Donna Rowen, Sarah Acaster, et al.
Social Science & Medicine (1982)|February 4, 2026
Departures from health universalism? A value set of AP-7D in Japan as an attempt to develop a "culture-specific" preference-based measureTakeru Shiroiwa, Yasuhiro Morii, Eri Hoshino, et al.
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2023
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study ProtocolDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2022
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?Juan M Ramos-Goñi, Anabel Estévez-Carrillo, Oliver Rivero-Arias, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Epilepsy & Behavior : E&B|May 20, 2014
Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general populationBrendan Mulhern, Donna Rowen, Dee Snape, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Deriving a preference-based measure for cancer using the EORTC QLQ-C30Donna Rowen, John Brazier, Tracey Young, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 17, 2015
Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of LifeDonna Rowen, John Brazier, Clara Mukuria, et al.
Pharmacoeconomics|June 11, 2026
Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with DurationEun-Young Bae, Jahyun Cho, Jooho Moon, et al.
Journal of Patient-Reported Outcomes|February 28, 2024
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosisClara Mukuria, Donna Rowen, Sarah Acaster, et al.
Social Science & Medicine (1982)|February 4, 2026
Departures from health universalism? A value set of AP-7D in Japan as an attempt to develop a "culture-specific" preference-based measureTakeru Shiroiwa, Yasuhiro Morii, Eri Hoshino, et al.
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2023
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study ProtocolDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2022
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?Juan M Ramos-Goñi, Anabel Estévez-Carrillo, Oliver Rivero-Arias, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Pageof 13